Sigma Foods (SIGMAF) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Completed transformation into a focused food company, divesting non-core assets and spinning off Alpek, with rebranding and board reconfiguration underway to align with the new strategy.
S&P upgraded credit rating to 'BBB', citing improved leverage and a simplified business structure.
Four independent businesses now operate: Sigma (food), Alpek (petrochemical), Nemak (automotive), and Axtel (telecom).
Board reconfiguration and rebranding to a Sigma-related name are underway, with trading tickers to be updated by year-end.
$83 million cash dividend declared at the annual shareholders' meeting.
Financial highlights
1Q25 EBITDA reached US$220 million, down 42% year-over-year, mainly due to Torrente plant flooding and FX headwinds; insurance reimbursements expected.
Revenue for 1Q25 was US$2,064 million, down 5% year-over-year, primarily due to FX effects.
Majority Net Income for 1Q25 was US$66 million for Sigma, up from US$12 million in 4Q24.
Net Debt for Sigma at quarter-end was US$1,975 million, down 5% year-over-year.
EBITDA margin contracted to 10.3% in 1Q25 from 12.7% in 1Q24 due to cost pressures and temporary plant impact.
Outlook and guidance
Full-year guidance reaffirmed, with results on track to meet US$1 billion EBITDA target.
Margin recovery expected as price increases are implemented and insurance proceeds offset flooding impact.
Insurance reimbursements for Torrente-related costs expected before year-end.
Ongoing focus on core business growth, new revenue streams, organizational development, and health-focused innovation.
Latest events from Sigma Foods
- Record 2Q26 revenue and EBITDA growth drive confidence in full-year $1.1B guidance.SIGMAF
Q2 202622 Jul 2026 - Sigma posts record EBITDA as ALFA finalizes Alpek spin-off and reduces leverage.SIGMAF
Q3 20248 Jul 2026 - EBITDA and guidance rose on Sigma's record results, with leverage and debt reduction improving.SIGMAF
Q2 20248 Jul 2026 - Record revenue and EBITDA growth driven by brand strength, efficiency, and innovation.SIGMAF
Corporate presentation3 Jun 2026 - Record Q1 volume, revenue, and EBITDA growth, with 2026 guidance reaffirmed.SIGMAF
Q1 202627 Apr 2026 - Record revenues, margin expansion, Alpek spin-off, and strong 2026 outlook with increased dividends.SIGMAF
Q4 202512 Apr 2026 - Record 4Q25 EBITDA, strong innovation, and sustainability progress drive growth outlook.SIGMAF
Corporate presentation25 Feb 2026 - Record results and transformation position for growth as Alpek spin-off nears completion.SIGMAF
Q4 202419 Dec 2025 - Record revenues and sequential EBITDA gains despite cost and operational headwinds.SIGMAF
Q3 202514 Dec 2025